Home
About
Overview
Sharing Data
ORCID
Help
History (3)
ACR Appropriateness Criteria® Tracheobronchial Disease.
Longer time from diagnosis to initiation of hypomethylating agents plus venetoclax for acute myeloid leukemia does not worsen survival: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).
Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax?+?Hypomethylating Agent.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
ACR Appropriateness Criteria® Tracheobronchial Disease.
ACR Appropriateness Criteria® Tracheobronchial Disease. J Am Coll Radiol. 2024 Nov; 21(11S):S518-S533.
View in:
PubMed
subject areas
Bronchial Diseases
Diagnostic Imaging
Evidence-Based Medicine
Humans
Radiography, Thoracic
Societies, Medical
Tracheal Diseases
United States
authors with profiles
Jonathan Chung